 |
|
Placebo in Clinical Trials for Depression
Complexity and Necessity
David J. Kupfer, MD;
Ellen Frank, PhD
JAMA. 2002;287:1853-1854.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Within the last several years, the long-simmering debate about the ethical issues surrounding placebo administration in randomized clinical trials has reached new levels of intensity. The report of the National Bioethics Advisory Commission included specific recommendations for studies involving more than minimal risk, including the use of placebo controls in clinical trials.1 At a time of increased interest in drug discovery in medicine and the potential need for definitive randomized clinical trials, the controversy over the ethical issues places an appropriate burden on the scientific community to justify the use of placebo controls.2-3 One argument is that placebo administration is not appropriate if effective treatment for a condition exists and that assessment of efficacy can be conducted with active controls. Another view is that placebo controls may be necessary to determine the assay sensitivity of a trial and are ethical if patients provide . . . [Full Text of this Article]
Author Affiliations: Department of Psychiatry, University of Pittsburgh Medical School, Western Psychiatric Institute and Clinic, Pittsburgh, Pa.
RELATED ARTICLES
Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder: A Randomized Controlled Trial
Hypericum Depression Trial Study Group
JAMA. 2002;287(14):1807-1814.
ABSTRACT
| FULL TEXT
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
B. Timothy Walsh, Stuart N. Seidman, Robyn Sysko, and Madelyn Gould
JAMA. 2002;287(14):1840-1847.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Ethical aspects of placebo groups in pain trials: Lessons from psychiatry
Nagasako and Kalauokalani
Neurology 2005;65:S59-S65.
ABSTRACT
| FULL TEXT
Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
Solyom
JAMA 2004;291:41-42.
FULL TEXT
Progress in the Therapy of Mood Disorders: Scientific Support
Frank and Kupfer
Am. J. Psychiatry 2003;160:1207-1208.
FULL TEXT
Consent to open label extension studies: some ethical issues
Wainwright
J. Med. Ethics 2002;28:373-376.
ABSTRACT
| FULL TEXT
St John's wort was not better than placebo for reducing symptoms in major depressive disorder
Swann
Evid. Based Ment. Health 2002;5:111-111.
FULL TEXT
Diversity, the Individual, and Proof of Efficacy: Complementary and Alternative Medicine in Medical Education
Park
Am. J. Public Health 2002;92:1568-1572.
ABSTRACT
| FULL TEXT
St John's Wort and Depression
Jonas et al.
JAMA 2002;288:446-449.
FULL TEXT
No Benefit of St. John's Wort in Major Depression
JWatch Psychiatry 2002;2002:9-9.
FULL TEXT
No Benefit of St. John's Wort in Major Depression
Journal Watch Dermatology 2002;2002:8-8.
FULL TEXT
No Benefit of St. John's Wort in Major Depression
JWatch General 2002;2002:2-2.
FULL TEXT
|
